Figure 2. The combination of carfilzomib and TGR-1202 inhibited TCL cells in a highly synergistic manner at 48-hour of exposure.
Figure 2

The combination of carfilzomib and TGR-1202 inhibited TCL cells in a highly synergistic manner at 48-hour of exposure.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal